• Low cost Ayurvedic medicine for diabetes launched in Patna Low cost Ayurvedic medicine for diabetes launched in Patna

    24 Feb , 2016

              A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow). The medicine was launched here yesterday at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical Research...           A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow). The medicine was launched here yesterday at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical Research...

    CONTINUE READING

  • BGR-34 launched in Punjab, newspaper coverage BGR-34 launched in Punjab, newspaper coverage

    23 Feb , 2016

    Senior scientists of the Council for Scientific and Industrial Research, the National Botanical Research Institute and the Central Institute for Medicinal and Aromatic Plants launch the anti-diabetic drug, BGR-34, in Chandigarh.  Tribune News Service Chandigarh, February 15 Council for Scientific and Industrial Research (CSIR) launched BGR-34 – country’s first anti-diabetic ayurvedic drug with DPP4 inhibitory activity, here today. BGR-34, designed for type 2 diabetes mellitus, has been scientifically validated for... Senior scientists of the Council for Scientific and Industrial Research, the National Botanical Research Institute and the Central Institute for Medicinal and Aromatic Plants launch the anti-diabetic drug, BGR-34, in Chandigarh.  Tribune News Service Chandigarh, February 15 Council for Scientific and Industrial Research (CSIR) launched BGR-34 – country’s first anti-diabetic ayurvedic drug with DPP4 inhibitory activity, here today. BGR-34, designed for type 2 diabetes mellitus, has been scientifically validated for...

    CONTINUE READING